The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of Life
Abstract
PURPOSE: To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL). PATIENTS AND METHODS: A four-question screening questionnaire was developed and mailed to a random sample of 744 breast cancer patients treated curatively in two cancer centers from 1993 to 1997. Patients were without recurrence and at least 2 years from diagnosis. Respondents were classified as with or without arm-related symptoms on the basis of the survey. Stratified random samples from each group were then invited for a detailed assessment of their symptoms and signs, including the presence of lymphedema. Their QOL was assessed by the European Organization for Research and Treatment of Cancer QOL Questionnaire C-30 and by a detailed arm problem questionnaire that assessed various aspects of daily arm functioning. RESULTS: Approximately half of all screened patients were symptomatic and 12.5% of all assessed patients had lymphedema. Axillary dissection (AD) and axillary radiotherapy (RT) after dissection were statistically significantly related to the occurrence of arm symptoms (odds ratio for AD = 3.3, P < .001; odds ratio for RT = 3.1, P < .001). Symptomatic patients and patients with lymphedema both had impaired QOL compared with asymptomatic patients. CONCLUSION: Treatment for breast cancer is associated with considerable arm morbidity, which has a negative impact on QOL. Arm morbidity should be carefully monitored in future studies involving local treatment modalities for breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Self-citationRisk of lymphoedema following the treatment of breast cancer
Kissin, M. W., Della Rovere, G. Q., Easton, D., & Westbury, G. (1986) · Journal of British Surgery · doi:10.1002/bjs.1800730723 · Cited by 716
Arm edema in breast cancer patients
Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., & Kahn, K. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.96 · Cited by 560
Larson, D., Weinstein, M., Goldberg, I., Silver, B., Recht, A., Cady, B., Silen, W., & Harris, J. R. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90280-4 · Cited by 374
Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer
Hack, T. F., Cohen, L., Katz, J., Robson, L. S., & Goss, P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.143 · Cited by 351
Complications of axillary lymph node dissection for carcinoma of the breast
Warmuth, M. A., Bowen, G., Prosnitz, L. R., Chu, L., Broadwater, G., Peterson, B. L., Leight, G. S., & Winer, E. P. (1998) · Cancer · Cited by 244
Kuehn, T., Klauss, W., Darsow, M., Regele, S., Flock, F., Maiterth, C., Dahlbender, R., Wendt, I., & Kreienberg, R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1026564723698 · Cited by 230
Conservation treatment of early breast cancer: Long term results and complications
Delouche, G., Bachelot, F., Premont, M., & Kurtz, J. M. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90256-2 · Cited by 225
Liljegren, G., & Holmberg, L. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00375-9 · Cited by 156
Arm Morbidity after Breast-conserving Therapy for Breast Cancer
Tengrup, I., Tennvall-Nittby, L., Christiansson, I., & Laurin, M. (2000) · Acta Oncologica · doi:10.1080/028418600750013177 · Cited by 155
Højris, I., ANDERSEN, J. E., Overgaard, M., & Overgaard, J. (2000) · Acta Oncologica · doi:10.1080/028418600750013131 · Cited by 136
Treatment Morbidity Associated with the Management of the Axilla in Breast-Conserving Therapy
Johansen, J., Overgaard, J., Blichert-Toft, M., & Overgaard, M. (2000) · Acta Oncologica · doi:10.1080/028418600750013122 · Cited by 112
Investigation and management of lymphoedema
Mortimer, P. S. (1990) · Vascular Medicine Review · doi:10.1177/1358836x9000100102 · Cited by 90
Cited by
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70076-7 · Cited by 1,885
Montazeri, A. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-32 · Cited by 770
Wilke, L. G., McCall, L. M., Posther, K. E., Whitworth, P. W., Reintgen, D. S., Leitch, A. M., Gabram, S. G. A., Lucci, A., Cox, C. E., Hunt, K. K., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.013 · Cited by 580
Lymphoedema: an underestimated health problem
Moffatt, C. J., Franks, P. J., Doherty, D. C., Williams, A. F., Badger, C., Jeffs, E., Bosanquet, N., & Mortimer, P. S. (2003) · QJM · doi:10.1093/qjmed/hcg126 · Cited by 557
Preoperative assessment enables the early diagnosis and successful treatment of lymphedema
Stout Gergich, N. L., Pfalzer, L. A., McGarvey, C., Springer, B., Gerber, L. H., & Soballe, P. (2008) · Cancer · doi:10.1002/cncr.23494 · Cited by 470
Metadata
- Authors
- Kwan, W., Jackson, J., Weir, L. M., Dingee, C., McGregor, G., & Olivotto, I. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-10-15
- Volume
- 20
- Issue
- 20
- Pages
- 4242-4248
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2104141617
- Cited by
- 357
- References
- 14
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.